Literature DB >> 18507688

Stones from cancerous and benign gallbladders are different: A proton nuclear magnetic resonance spectroscopy study.

Madhulika Srivastava1, Ajay Sharma, Vinay K Kapoor, Gowda A Nagana Gowda.   

Abstract

AIM: Gallbladder cancer (GBC) is frequently associated with gallstones (GS). At the same time, however, a very small number of patients with GS develop GBC. Cholesterol and metal salts are the common constituents of all GS. To understand their role in the etiopathogenesis of GBC, cholesterol, calcium, and magnesium composition in GS is compared in cancerous and benign gallbladders.
METHODS: GS from patients with GBC (n = 11), chronic cholecystitis (CC; n = 23), and xanthogranulomatous cholecystitis (XGC; n = 11) undergoing cholecystectomy were analyzed using proton nuclear magnetic resonance spectroscopy. The diagnosis of the gallbladder disease was based on histopathological examinations. Cholesterol, calcium, and magnesium in the GS of GBC, XGC, and CC were analyzed, compared, and correlated using statistical methods.
RESULTS: The quantity of cholesterol was significantly less in the GS of GBC than in benign gallbladder diseases (CC or XGC, P < 0.0001 for both). Both calcium and magnesium were significantly higher in GBC than in benign disease (calcium: P < 0.0005 and magnesium: P < 0.0001 for GBC vs CC; calcium: P < 0.02 and magnesium: P < 0.04 for GBC vs XGC). In all the GS, calcium was higher than magnesium. Calcium and magnesium were positively correlated in GBC (R = 0.69) and XGC (R = 0.75), and cholesterol and calcium were negatively correlated in CC (R =-0.61).
CONCLUSION: Differences in the GS composition between malignant and benign gallbladder patients may provide useful clues to the etiopathogenesis of GBC. These clues could lead to the identification of patients with GS in vivo who are at high risk of developing GBC, and advocate prophylactic cholecystectomy to prevent GBC.

Entities:  

Year:  2008        PMID: 18507688     DOI: 10.1111/j.1872-034X.2008.00356.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  6 in total

Review 1.  Xanthogranulomatous cholecystitis: a European and global perspective.

Authors:  Matthew David Hale; Keith J Roberts; James Hodson; Nigel Scott; Maria Sheridan; Giles J Toogood
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 2.  Advances in NMR-based biofluid analysis and metabolite profiling.

Authors:  Shucha Zhang; G A Nagana Gowda; Tao Ye; Daniel Raftery
Journal:  Analyst       Date:  2010-04-09       Impact factor: 4.616

3.  Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.

Authors:  Sung-Chan Gwark; Shin Hwang; Ki-Hun Kim; Yong-Joo Lee; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

Review 4.  Systematic review: should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer?

Authors:  Parul J Shukla; Savio G Barreto
Journal:  Saudi J Gastroenterol       Date:  2010 Jul-Sep       Impact factor: 2.485

Review 5.  MRS-based Metabolomics in Cancer Research.

Authors:  Tedros Bezabeh; Omkar B Ijare; Alexander E Nikulin; Rajmund L Somorjai; Ian Cp Smith
Journal:  Magn Reson Insights       Date:  2014-02-13

6.  Gallstones: A Worldwide Multifaceted Disease and Its Correlations with Gallbladder Carcinoma.

Authors:  Raj Kumar Sharma; Kanchan Sonkar; Neeraj Sinha; Pradeep Rebala; Ahmad Ebrah Albani; Anu Behari; Duvvuri Nageshwar Reddy; Alvina Farooqui; Vinay Kumar Kapoor
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.